Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record is now available, with details on the completed trial of a helper peptide vaccine plus pembrolizumab for melanoma, including eligibility criteria, study measures, and a protocol document. Previously, the page displayed a forbidden-access error.
    Difference
    52%
    Check dated 2026-11-08T14:40:16.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:49:38.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH website transition and says that some NIH content will use “Super Intelligence” in place of “Artificial Intelligence”.
    Difference
    1%
    Check dated 2026-10-25T15:48:58.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision updated from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:44:19.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T20:53:24.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating the page is currently inaccessible.
    Difference
    19%
    Check dated 2026-09-20T22:31:23.000Z thumbnail image

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.